Membrane Vesicle-Mediated Delivery of Antibacterial Lipopeptides by Pseudoalteromonas piscicida
ACS Chemical Biology · 2026-04-17 · 21 (4) · 751-763
DOI: 10.1021/acschembio.5c01016 ↗At a glance
Journal article in ACS Chemical Biology, published online on 2026-02-27. Written by Ololade S Gbadebo and 7 co-authors. Institution: Department of Biomedical & Pharmaceutical Sciences, College of Pharmacy, The University of Rhode Island, Kingston, Rhode Island 02881, United States. Major MEDLINE topics: Pseudoalteromonas, Anti-Bacterial Agents, Lipopeptides. Cited 3 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, National Institute of Food and Agriculture, School of Pharmacy, University of Pittsburgh.
Abstract (original language)
Bacterial membrane vesicles (MVs) are natural delivery systems for biomolecules, such as enzymes and nucleic acids, but their role in transporting specialized metabolites is less understood. Many microbial metabolites are lipophilic and poorly water-soluble, raising questions about how they perform ecological functions in aquatic environments. Here, we demonstrate that Pseudoalteromonas piscicida JC3, a marine bacterium with probiotic potential, packages lipophilic depsipeptides known as bromoalterochromides (BACs) into outer membrane vesicles. Untargeted metabolomics and molecular networking identified six known and two previously unknown BACs, while targeted LC-MS/MS localized BACs to MVs and cells, with no detection in culture supernatants. Structure elucidation of a new analogue, bromoalterochromide E/E', was achieved through isolation and spectroscopic analysis, including modified Marfey's analysis to determine amino acid composition and chirality. Functional assays showed that BAC-loaded MVs exhibit antibacterial activity against Staphylococcus aureus and the marine pathogen Vibrio anguillarum, linking vesicle-mediated metabolite delivery to microbial competition. These findings highlight MVs as transporters of lipophilic natural products and suggest their potential as natural drug delivery vehicles in clinical and aquaculture settings.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biomedical & Pharmaceutical Sciences, College of Pharmacy, The University of Rhode Island, Kingston, Rhode Island 02881, United States.
- Biological Sciences Department, College of Arts and Sciences, Cavite State University, Indang, Cavite 4122, Philippines.
- Bioinformatics Group, Wageningen University, Droevendaalsesteeg 1, Wageningen 6708 PB, Netherlands.
- Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States.
- Department of Fisheries, Animal and Veterinary Sciences, The University of Rhode Island, Kingston, Rhode Island 02881, United States.
ORCID profiles: Ololade S Gbadebo, Qihao Wu, David C Rowley
Funding
- NIGMS NIH HHS
- National Institute of Food and Agriculture
- School of Pharmacy, University of Pittsburgh
Cite
APA
Gbadebo, O. S., Masibag, A. G., Rosario, M. E., He, R., Ye, Y. S., Gomez-Chiarri, M., Wu, Q., & Rowley, D. C. (2026). Membrane Vesicle-Mediated Delivery of Antibacterial Lipopeptides by Pseudoalteromonas piscicida. ACS Chemical Biology, 21(4), 751-763. https://doi.org/10.1021/acschembio.5c01016
Vancouver
Gbadebo OS, Masibag AG, Rosario ME, He R, Ye YS, Gomez-Chiarri M, et al. Membrane Vesicle-Mediated Delivery of Antibacterial Lipopeptides by Pseudoalteromonas piscicida. ACS Chemical Biology. 2026;21(4):751-763. doi:10.1021/acschembio.5c01016
BibTeX
@article{Gbadebo2026,
author = {Gbadebo, Ololade S and Masibag, Arvie Grace and Rosario, Margaret E and He, Ruolin and Ye, Yan-Song and Gomez-Chiarri, Marta and Wu, Qihao and Rowley, David C},
title = {Membrane Vesicle-Mediated Delivery of Antibacterial Lipopeptides by Pseudoalteromonas piscicida},
journal = {ACS Chemical Biology},
year = {2026},
volume = {21},
number = {4},
pages = {751--763},
doi = {10.1021/acschembio.5c01016}
}
EUVIMED